Cargando…

Breast Carcinoma Receptor Expression in a Caribbean Population

Trinidad and Tobago are islands in the Southern Caribbean with a unique mix of races within the population consisting of East Indian (EI) (37.6%), Afro-Caribbean (AC) (36.3%), mixed (24.2%), and Caucasian, Chinese, Lebanese, Syrian, Amerindian, and Spanish groups accounting for 1.9%. It makes it sui...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramdass, Michael J., Gonzales, Joshua, Maharaj, Dale, Simeon, Donald, Barrow, Shaheeba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical Publishers, Inc. 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484866/
https://www.ncbi.nlm.nih.gov/pubmed/36131945
http://dx.doi.org/10.1055/s-0042-1756632
_version_ 1784791965854859264
author Ramdass, Michael J.
Gonzales, Joshua
Maharaj, Dale
Simeon, Donald
Barrow, Shaheeba
author_facet Ramdass, Michael J.
Gonzales, Joshua
Maharaj, Dale
Simeon, Donald
Barrow, Shaheeba
author_sort Ramdass, Michael J.
collection PubMed
description Trinidad and Tobago are islands in the Southern Caribbean with a unique mix of races within the population consisting of East Indian (EI) (37.6%), Afro-Caribbean (AC) (36.3%), mixed (24.2%), and Caucasian, Chinese, Lebanese, Syrian, Amerindian, and Spanish groups accounting for 1.9%. It makes it suitable for a comparison of breast carcinoma receptor expression within a fixed environment. This study included 257 women with an age range of 28 to 93 years (mean = 57.2, standard deviation = 15.0), peak age group of 51 to 60 consisting of 105 EI, 119 AC, and 33 mixed descent. Invasive ductal carcinoma accounted for 88%, invasive lobular 9.7%, and ductal carcinoma in situ 2.3%. The triple-negative rates were 24.8, 33.6, and 30.3% for EI, AC, and mixed races, respectively, with the Pearson's chi-square test revealing statistical significance for the AC versus EI ( p  < 0.001); AC versus mixed ( p  < 0.001); and EI versus mixed ( p  = 0.014) groups. The overall estrogen (ER), progesterone (PR), and human epidermal growth receptor (HER) expression negative rates were 52, 64, and 79%, respectively. Chi-square test of the following combinations: ER +/PR +/HER + ; ER +/PR +/HER − ; ER −/PR −/HER + ; ER +/PR −/HER + ; ER +/PR −/HER − ; ER −/PR +/HER + ; ER −/PR +/HER− revealed no statistical differences ( p  = 0.689).
format Online
Article
Text
id pubmed-9484866
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Thieme Medical Publishers, Inc.
record_format MEDLINE/PubMed
spelling pubmed-94848662022-09-20 Breast Carcinoma Receptor Expression in a Caribbean Population Ramdass, Michael J. Gonzales, Joshua Maharaj, Dale Simeon, Donald Barrow, Shaheeba Surg J (N Y) Trinidad and Tobago are islands in the Southern Caribbean with a unique mix of races within the population consisting of East Indian (EI) (37.6%), Afro-Caribbean (AC) (36.3%), mixed (24.2%), and Caucasian, Chinese, Lebanese, Syrian, Amerindian, and Spanish groups accounting for 1.9%. It makes it suitable for a comparison of breast carcinoma receptor expression within a fixed environment. This study included 257 women with an age range of 28 to 93 years (mean = 57.2, standard deviation = 15.0), peak age group of 51 to 60 consisting of 105 EI, 119 AC, and 33 mixed descent. Invasive ductal carcinoma accounted for 88%, invasive lobular 9.7%, and ductal carcinoma in situ 2.3%. The triple-negative rates were 24.8, 33.6, and 30.3% for EI, AC, and mixed races, respectively, with the Pearson's chi-square test revealing statistical significance for the AC versus EI ( p  < 0.001); AC versus mixed ( p  < 0.001); and EI versus mixed ( p  = 0.014) groups. The overall estrogen (ER), progesterone (PR), and human epidermal growth receptor (HER) expression negative rates were 52, 64, and 79%, respectively. Chi-square test of the following combinations: ER +/PR +/HER + ; ER +/PR +/HER − ; ER −/PR −/HER + ; ER +/PR −/HER + ; ER +/PR −/HER − ; ER −/PR +/HER + ; ER −/PR +/HER− revealed no statistical differences ( p  = 0.689). Thieme Medical Publishers, Inc. 2022-09-19 /pmc/articles/PMC9484866/ /pubmed/36131945 http://dx.doi.org/10.1055/s-0042-1756632 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ ) https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Ramdass, Michael J.
Gonzales, Joshua
Maharaj, Dale
Simeon, Donald
Barrow, Shaheeba
Breast Carcinoma Receptor Expression in a Caribbean Population
title Breast Carcinoma Receptor Expression in a Caribbean Population
title_full Breast Carcinoma Receptor Expression in a Caribbean Population
title_fullStr Breast Carcinoma Receptor Expression in a Caribbean Population
title_full_unstemmed Breast Carcinoma Receptor Expression in a Caribbean Population
title_short Breast Carcinoma Receptor Expression in a Caribbean Population
title_sort breast carcinoma receptor expression in a caribbean population
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484866/
https://www.ncbi.nlm.nih.gov/pubmed/36131945
http://dx.doi.org/10.1055/s-0042-1756632
work_keys_str_mv AT ramdassmichaelj breastcarcinomareceptorexpressioninacaribbeanpopulation
AT gonzalesjoshua breastcarcinomareceptorexpressioninacaribbeanpopulation
AT maharajdale breastcarcinomareceptorexpressioninacaribbeanpopulation
AT simeondonald breastcarcinomareceptorexpressioninacaribbeanpopulation
AT barrowshaheeba breastcarcinomareceptorexpressioninacaribbeanpopulation